←Back to Expert Scholars
Translational Medicine / 转化医学Ocular/Conjunctival Melanoma
Joseph Sacco
MD, PhD
🏢University of Liverpool / Clatterbridge Cancer Centre🌐UK
Professor of Medical Oncology
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Joseph Sacco led European development of tebentafusp (ImmTAC) for metastatic uveal melanoma. His work established the first survival-improving therapy for this disease. He continues to investigate novel bispecific approaches in rare melanoma subtypes.
Share:
🧪Research Fields 研究领域
Uveal melanoma
Tebentafusp
IMCgp100 biology
European trials
ImmTAC therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Joseph Sacco 的研究动态
Follow Joseph Sacco's research updates
留下邮箱，当我们发布与 Joseph Sacco（University of Liverpool / Clatterbridge Cancer Centre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment